Introduction to the AutoCAD 2009 Ribbon | The CAD Geek Blog

Last Tuesday MSNBC, CNN, and every other American news outlet dubbed February 5, 2008 as “Super Tuesday”.  Seeing that Virginia (where I live) wasn’t included in the Super Tuesday primaries; Super Tuesday wasn’t much different than any other Tuesday.  Fast-forward a week to February 12, 2008, and you get what I call a Super Tuesday!  Autodesk had some pretty exciting announcements to make.  No Carl Bass (Autodesk CEO) isn’t running for president.  Instead, what Autodesk is about to do is release their line of 2009 products, and you know what that means.  An all new AutoCAD, Civil 3D, and the many other Autodesk products!

So what can we expect in AutoCAD 2009?  Well the list is somewhat long.  If you would like to see the complete list, hop over to Shaan Hurley’s Between The Lines Blog, and check out his The 2009 Products Including AutoCAD 2009 post.  Stay tuned here at The CAD Geek Blog for some indepth looks at the new features within both AutoCAD 2009 and AutoCAD Civil 3D 2009.

...

Read more...

acad 2009 - News
ACADIA Pharmaceuticals Inc. (ACAD) Reports Q3 Results
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) yesterday reported its third-quarter financial results, with revenues at $2.3 million as compared to $2.4 million

Housing transactions & prices rise
This is the sixth consecutive month in which the market has seen a marginal gain in price, reveals the LSL/Acad HPI Year on year house price growth slowed

The Ties That Bind: Maternal-Infant Interactions and the Neural Circuitry of ...
J Am Acad Child Adolesc Psychiatry 2009; 48:919–927[CrossRef][Medline] Moses-Kolko EL, Perlman SB, Wisner KL, James J, Saul AT, Phillips ML: Abnormally

Is Etanercept Safe for Treating Plaque Psoriasis in a Patient With Chronic ...
Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009;61(6):1044-1055.

ACADIA Pharmaceuticals Reports Third Quarter 2010 Financial Results
SAN DIEGO, Nov 09, 2010 (BUSINESS WIRE) -- ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) , a biopharmaceutical company utilizing innovative technology to fuel